Editors-in-Chief Profile

Dr. Yan-Gao Man received his medical degree in 1978 and MS in Microbiology in 1985 from Hubei Medical College of China, and PhD in Cell Biology/Anatomy from Howard University Medical School, Washington DC, in 1998. He received postdoctoral training in Cancer Biology from National Cancer Institute in 1999. His research interests focus on the mechanism and early detection of tumor progression, invasion, and metastasis. After postdoctoral training, he has authored or co-authored over 160 scientific publications, and received 15 external and internal funding for cancer research. He has published 14 novel protocols for immunohistochemical- and molecular assays, and introduced several novel hypotheses for tumor progression, invasion, and metastasis. These hypotheses have gained increased popularity, and he has been invited by a number of world’s prestigious institutes, including Dana-Farber Cancer Institute of Harvard Medical School, National Institutes of Health, and Barbara Ann Karmanos Cancer Institute, to present the hypotheses. Dr. Man worked as the director of Gynecological and Breast Research Laboratory, Armed Forces Institute of Pathology and American Registry of Pathology between 1995 and 2011. He is a visiting professor of Jilin University, China, an editorial board member of The Open Breast Cancer Journal, associate editor-in-chief of Cancer Epidemiology—International Journal of Cancer Epidemiology, Detection, and Prevention, and co-editor-in-chief of Journal of Cancer. He serves as a grant review panel member for a number of international and national cancer-research related organizations. Before March 2013, he was a Senior Distinguished Scientist in Diagnostic and Translational Research Center, Henry Jackson Foundation for the Advancement of Military Medicine. Currently, he is Vice president for Research and Collaboration, South Hospital of Nanjing, Nanjing, China

Dr. Man's contact information is as follows:
Dr. Yan-Gao Man, Diagnostic and Translational Research Center, Henry Jackson Foundation for the Advancement of Military Medicine, 401 Professional Drive, Gaithersburg, 20879, USA. Phone: 301-326-6731; Fax: 301-879-0816.

Email:

Dr. Naoto T. Ueno gained his medical degree in 1989 from Wakayama Medical College, Wakayama, Japan, and PhD in Cancer Biology from The University of Texas Graduate School of Biomedical Sciences, Houston, TX, in 1999. He is currently full professor and Chief of the Translational Breast Cancer Research Section of Department of Breast Medical Oncology, and Executive Director of the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center. He also serves as the Committee Chair of Solid Tumor Committee of Center for International Blood & Marrow Transplant Research (CIBMTR), Milwaukee, WI. Dr. Ueno is on Board of Directors for Japan Comprehensive Cancer Network, Breast (Tokyo, Japan), Chair of Sister Institution between Tokyo Oncology Consortium and MD Anderson Cancer Center, and Chair of MD Anderson Cancer Center Breast Cancer Bone Metastasis Working Group. Dr. Ueno was Chair of The European Group for Blood & Marrow Transplantation, 2nd International Meeting of Allogeneic Transplantation for Solid Tumor, Milan, Italy, 2005, and Chair of The European Group for Blood & Marrow Transplantation, 3rd International Meeting of Allogeneic Transplantation for Solid Tumor, Siena, Italy, 2008. Dr. Ueno's primary research interest is dissecting the molecular events related to cytotoxicity induced by chemotherapy or targeted therapy for breast cancer and ovarian cancer. His research is well funded by NIH and Susan G. Komen Breast Cancer Foundation. Dr. Ueno is author or co-author of more than 120 articles in peer-reviewed journals, 17 book chapters, and 46 abstracts.

Dr. Ueno's contact information is as follows:
Naoto T. Ueno, M.D., Ph.D., F.A.C.P., The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1354, Houston, TX 77030, USA. Phone: 713-792-8754; Fax: 713-794-4385

Updated on March 2, 2013

Email: